Journals / Türk Oftalmoloji Dergisi / 2012 / Cilt: 42 - Sayı: 2

Allograft reaction after latanoprost use following penetrating keratoplasty for corneal scarring due to herpetic keratitis

Herpetik keratit skarı nedeniyle penetran keratoplasti yapılan olguda latanoprost kullanımı sonrası görülen allograft reaksiyonu

Pages
150–153
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, oral acyclovir prophylaxis together with AR therapy would improve graft success in cases with HSV history. (Turk J Oph thal mol 2012; 42: 150-3)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 27-year-old male patient with a corneal scar secondary to herpetic keratitis in the right eye underwent penetrating keratoplasty (PK).
📊
Key Findings & Data:At the 14th month of follow-up, latanoprost was started to treat high intraocular pressure which was refractory to treatment.
💡
Conclusion & Impact:For this reason, oral acyclovir prophylaxis together with AR therapy would improve graft success in cases with HSV history. (Turk J Oph thal mol 2012; 42: 150-3)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

A 27-year-old male patient with a corneal scar secondary to herpetic keratitis in the right eye underwent penetrating keratoplasty (PK). At the 14th month of follow-up, latanoprost was started to treat high intraocular pressure which was refractory to treatment. On the 15th day of latanoprost use, allograft reaction (AR) developed. Insufficient clinical response despite intensive immunosuppressive therapy made us consider the possibility of recurrent herpetic keratouveitis secondary to steroid treatment. The dramatic reduction in the number of keratic precipitates with oral valacyclovir treatment confirmed this diagnosis. The graft remained clear 3 months after the AR treatment. Inflammation in eyes that had undergone PK jeopardizes the graft success by disrupting the immune privilege of anterior chamber. Considering the effects of prostaglandin analogues on blood-aqueous barrier, latanoprost use might have been related to allograft reaction in this case. Another remarkable characteristics of this case was the herpes simplex virus (HSV) reactivation secondary to AR therapy. For this reason, oral acyclovir prophylaxis together with AR therapy would improve graft success in cases with HSV history. (Turk J Oph thal mol 2012; 42: 150-3)

Özet

Yirmi yedi yaşında erkek hastanın sağ gözüne herpetik keratite ikincil kornea skarı nedeniyle penetran keratoplasti (PK) uygulandı. Takip sürecinin 14.ayında tedaviye dirençli göz içi basıncı yüksekliği nedeniyle latanoprost başlandı. Tedavinin 15. gününde allograft reaksiyonu (AR) gelişti. Yoğun immunsüpresif tedaviye rağmen, yeterli cevabın alınamaması, steroid tedavisine ikincil herpetik keratoüveiti düşündürdü. Oral antiviral tedavi ile keratik presipitatların dramatik azalması, bu düşünceyi doğruladı. AR tedavisi sonrası 3. ayda greft saydamlığı devam etmektedir. PK yapılan gözlerde inflamasyon, ön kamaranın immun ayrıcalığını bozarak greft başarısını tehlikeye atabilmektedir. Prostaglandin analoglarının kan-aköz bariyeri üzerine etkileri göz önüne alındığında, bu olguda latanoprost kullanımının AR ile ilişkili olabileceği akla gelmektedir. Olguda dikkat çeken bir diğer özellik ise AR tedavisine ikincil olarak herpes simpleks virüs (HSV) reaktivasyonunun izlenmesidir. Bu nedenle, HSV hikayesi olan olgularda AR tedavisi ile beraber oral antiviral profilaksinin verilmesi greft başarısını arttıracaktır. (Turk J Ophthalmol 2012; 42: 150-3)

🔖

Cite This Article

BAHADIR, A. E., BOZKURT, T. K., AKTAY, S. K., ACAR, S. (2022). Allograft reaction after latanoprost use following penetrating keratoplasty for corneal scarring due to herpetic keratitis. Türk Oftalmoloji Dergisi, Cilt: 42 - Sayı: 2, 150–153. https://ajindex.com/articles/638228

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Liesegang TJ, Melton LJ 3rd, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107:1155-9
  2. Remeijer L, Doornenbal P, Geerards AJ, Rijneveld WA, Beekhuis WH. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology. 1997;104:648-52
  3. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-402
  4. LLomholt JA, Baggesen K, Ehlers N. Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis. Acta Ophthalmol. Scand 1995;73:29-32
  5. Panda A, Vanathi M, Kumar A, Dash Y, Priya S. Corneal graft rejection. Surv Ophthalmol. 2007;52:375-96
  6. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol. 1992;110:1392-403
  7. D'Amaro J, Volker-Dieben HJ, Kruit PJ, de Lange P, Schipper R. Influence of pretransplant sensitization on the survival of corneal allografts. Transplant Proc. 1991;23:368-72
  8. Cobo LM, Coster DJ, Rice NS, Jones BR. Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol. 1980;98:1755-9
  9. Ficker LA, Kirkness CM, Rice NS, Steele AD. The changing management and improved prognosis for corneal grafting in herpes simplex keratitis. Ophthalmology. 1989;96:1587-96
  10. Williams KA, Roder D, Esterman A, Muehlberg SM, Coster DJ. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. Ophthalmology. 1992;99:403-14
  11. Shtein RM, Garcia DD, Musch DC, Elner VM. Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection. Ophthalmology. 2009;116:1301-5
  12. Alm A, Grierson I, Shields MB. Side effects associated with prostaglandin analog therapy. Surv Ophthalmo.l 2008;53 Suppl1:S93-105
  13. Moroi SE, Gottfredsdottir MS, Schteingart MT, et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology. 1999;106:1024-9
  14. Lima MC, Paranhos A, Jr., Salim S, et al. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost. J Glaucoma. 2000;9:317-21
  15. Massry GG, Assil KK. Pilocarpine-associated allograft rejection i